Benzinga | Aug 5, 2021 04:50PM EDT

Asensus Surgical Q2 Adj. EPS $(0.05) Beats $(0.06) Estimate, Sales $1.10M Miss $1.50M Estimate

Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 76.19 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.10 million which missed the analyst consensus estimate of $1.50 million by 26.67 percent. This is a 67.94 percent increase over sales of $655.00 thousand the same period last year.